A new study on smoking and sarcoidosis

Researchers are working hard to identify the causes of sarcoidosis, but the answer is still unclear. They have found evidence suggesting that certain genetic and environmental factors may be involved. However, because many factors can interact, it is difficult to determine which ones truly have an effect. Many researchers believe that smoking is somehow connected with sarcoidosis, although there is disagreement about whether smoking is positively or negatively associated with the development of the disease. Several studies have been conducted, and they have produced different results.

A recent study published in Scientific Reports attempted to remove some of the variables that may have influenced the data in earlier studies, allowing researchers to examine more closely how smoking affects the development of sarcoidosis. To do this, the researchers included genetic information from all participants and conducted a population-based case-control study using a gene–environment interaction approach.


What is a case-control study?

A case-control study compares patients who have a particular disease with patients who do not have that disease. During the study, a risk factor is identified in both experimental groups, and researchers compare how often exposure to that risk factor affects people in each group. This information helps researchers determine the relationship between the risk factor and the disease. In this type of research, the researchers do not intervene. A case-control study is therefore purely observational and is intended to assess probability.

What is a gene–environment interaction approach?

To find out whether a particular gene and a particular environmental factor independently influence the development of disease, scientists must examine the interaction of these factors individually. The best way to do this is to observe whether the factors maintain the same effects when both are influenced by a third factor. If they do not, scientists can assume that the factors affect one another to some extent. In this study, the researchers tried to determine how smoking affects patients with sarcoidosis by examining separately the effects of smoking in patients with and without Löfgren syndrome, as well as in patients who do and do not carry the HLA-DRB1*03 allele, which is believed to have a particularly significant influence on the development of sarcoidosis.

Results

The results of our study showed that smoking modifies the risk of disease by 56% in Löfgren syndrome and by 62% in non-Löfgren syndrome when patients have both risk factors: the risk allele and smoking. These findings provide new insights into disease susceptibility and its interaction with exposure to smoking.

This means that smoking increases a person’s chances of developing sarcoidosis, but only if the person is already genetically susceptible. By isolating the relevant variables, the researchers were able to identify the circumstances in which smoking creates a greater risk of sarcoidosis. According to the study, both the HLA-DRB1*03 allele and the act of smoking must be present for smoking to increase a person’s risk of developing sarcoidosis. This is important information for the sarcoidosis community because it improves our understanding of what causes sarcoidosis. It can be assumed that both genetic and environmental factors increase the risk of sarcoidosis, and these factors often need to occur together.

Sources:

https://www.nature.com/articles/s41598-019-54612-1

https://himmelfarb.gwu.edu/tutorials/studydesign101/casecontrols.cfm

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823480/

Rating: 0 stars, 0 votes.